Wednesday, July 9, 2025
UG Standard - Latest News
  • Home
  • News
    • DIPLOMACY
    • COURT
    • AFRICA
    • BOOK REVIEW
    • INTERVIEW:
    • National
    • Parliament
    • World
    • Regional
  • Business
    • AGRIBUSINESS
    • OIL & GAS
    • REAL ESTATE
    • TECH
    • INNOVATIONS
    • TELCOM
  • OpED
  • EDUCATION
  • INVESTIGATION
    • NATIONAL ARCHIVE
    • SPECIAL REPORT
    • ANALYSIS
  • FEATURES
    • SOCIETY
    • Community
    • Pictorial
    • PROFILES
    • Lifestyle
    • Health
    • ENVIRONMENT
  • Tours & Travel
    • Hotel & Hospitality
  • Sports
  • About Us
  • Login
UG Standard - Latest News
ADVERTISEMENT

How big pharmaceuticals’ greed for profit harms lives

by UG STANDARD EDITOR | UG STANDARD EDITORIAL
07/05/2023
in OpED
Reading Time: 4 mins read
A A
0
Share on FacebookShare on Twitter

This is seemingly the same script but a different cast; the profiteering and greed of big pharma know no boundaries.

We have barely pulled out of the COVID-19 pandemic, during which big pharmaceutical companies once again insisted on putting profits before lives.

Related posts

UHRC Chairperson, Lady Justice Mariam Wangadya, Commissioners of UHRC and other stakeholders who participated in the workshop.

Human Rights Record: UHRC Prepares government agencies for UN periodic review

08/07/2025
180
Rtd General Mugisha Muntu addressing the gathering at Uganda Law Society headquarters on Thursday.

Ugandans should take a lead role towards the country’s peaceful transition

04/07/2025
159
Hon. Haruna Kasolo (seated middle) with other individuals who accompanied him at NRM offices in Kyadondo on Thursday.

Minister Kasolo nominated for NRM Vice Chairperson, Buganda Region

03/07/2025
213
The accused persons in court today.

Vandalism of Electricity Equipments: 17 charged with terrorism

02/07/2025
197

According to Action Aid, Moderna, BioNTech, and Pfizer were reaping astronomical and unconscionable profits due to their monopolies of mRNA COVID vaccines, with the three corporations having earned more than $26 billion in revenue in the first half of 2021.

This was despite the fact that taxpayers were the primary funders of COVID-19 vaccine research, development, and production – the world owns that intellectual property, not the drug companies that continue to profit from the pandemic. African countries have been pressurizing pharmaceutical companies to share their know-how and technology to increase local production and access to critical medicine in Africa and globally.

There must be a paradigm shift away from viewing sharing technology with Africa as charity or a threat to profitability. Africa should be treated as an equal partner in global health security that benefits every- one. With reasonable, non-predatory pricing and fair competition, Africa can still be an attractive market for pharmaceutical products.

Another large pharmaceutical company – Gilead Sciences is at it again, reaping billions from public coffers while at the same time risking the health and lives of the poor by continually hoarding patents that should be used for generic medicines.

According to Action Aid, Moderna, BioNTech, and Pfizer were reaping astronomical and unconscionable profits due to their monopolies of mRNA COVID vaccines, with the three corporations having earned more than $26 billion in revenue in the first half of 2021.
According to Action Aid, Moderna, BioNTech, and Pfizer were reaping astronomical and unconscionable profits due to their monopolies of mRNA COVID vaccines, with the three corporations having earned more than $26 billion in revenue in the first half of 2021.

Gilead Sciences is at the centre of a diabolical scheme of putting profits before people’s lives by deploying its power and clout to keep the costs of medicines high. Gilead Sciences is one of the worst offenders of big pharma profiteering, and at the same time, it has priced several of its HIV and hepatitis C drugs out of reach for many people.

Gilead Sciences is also yet to license technology for the production of medicines to treat cryptococcal meningitis to generic manufacturers. Cryptococcal meningitis may not be top of mind in public awareness, but it kills thousands annually despite the availability of safe and effective treatment options.

People most at risk of getting the fungal infection of the brain are those living with HIV in sub-Saharan Africa, in areas that are not deemed financially viable for pharmaceutical corporations.

As one of the world’s top 15 largest biopharmaceutical firms, Gilead Sciences generated over $27 billion in revenue and paid its CEO over $19 million in 2021 alone. In addition to overpricing lifesaving drugs, it has refused to register some medications in lower-income countries and consistently blocks attempts to introduce cheaper, generic versions of its medicines.

Africa is not in the position to sustain the development of the public health sector while it’s held in a pricing vise by Western pharmaceutical companies. For a continent that suffers greatly from HIV/AIDS, Africa’s response to the epidemic remains dependent on international donor funding because the debt burden is fanning mass cuts in health budgets and development spending.

The vicious debt burden is pushing countries in the Global South further into distress when it comes to funding public health. Presently, African countries invest less than three per cent of their GDP in healthcare, as opposed to five per cent as recommended by the African Union.

For instance, in Kenya, up to 75 per cent of funds for HIV, TB, and malaria programmes come from donors. AIDS Healthcare Foundation (AHF) is now taking its grassroots campaign global to raise awareness about Gilead’s shameful practices and calling out its greedy profiteering practices.

One of its most nefarious practices includes evergreening patents on existing HIV/AIDS drugs like Truvada – outright exploitation cloaked in the veil of innovation.

Through evergreening, drug companies ensure they maximise their benefits from patents which assure them of monopolistic power. While drug patents have a lifetime of two decades after the filing date, drug companies have devised tactics such as evergreening and thicketing to prolong a drug’s exclusivity.

Through evergreening, pharmaceutical companies make alterations to a drug, such as changing its chemical composition slightly or making an external tweak as minor as adding a stripe to a pill with the aim of preserving their patents. These patents ensure that prices remain high by reducing competition.

Gilead has harmed people living with HIV worldwide for over 20 years by securing continual patents and generating billions of dollars by creating a monopoly on some of the most effective and well-tolerated antiretroviral drugs to treat HIV.

As a leading global HIV/AIDS organization with over 1.7 million patients in care across 45 countries, including over 900,000 in 13 African countries, it is our responsibility at AHF to take a stand and call out Gilead so that governments and decision-makers everywhere put collective pressure on it to prioritize lives over obscenely high profits.

But people living with HIV are not the only ones affected by Gilead’s greed. There is also a need for Gilead Sciences to open the license for the generic production of the hepatitis C drug Harvoni to all low-and middle-income countries, without exception. Some of the deals the pharmaceutical company has signed in the past under the pretext of increasing access to Harvoni hides a clear strategy to prevent fair generic competition.

For example, this highly effective hepatitis C drug costs $1,000 per pill, and a 12-week course of treatment has a retail price of over $90,000 in the U.S. A generic version of the same drug costs only $4 per pill in India, but according to Médecins Sans Frontières, Gilead has excluded 50 middle- income countries from access to the generic, discounted price.

These excluded countries include Jamaica, Tunisia, the Philippines, Ukraine, and Venezuela, among others. Gilead must be held accountable for arbitrarily placing a price on who lives and who dies by keeping the most effective, modern, and lifesaving medicines out of reach of millions of people in low and middle-income countries.

For their generosity, the public and lower-income countries are rewarded with astronomical drug prices. Our global advocacy campaign is meant to let everyone know about Gilead’s greedy tactics and make lifesaving medicines accessible to everyone, not just people in rich countries. It is high time that Gilead stops the greed.

The author is the AIDS Healthcare Foundation (AHF) Africa Bureau chief

Share this:

  • Share
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Telegram (Opens in new window) Telegram
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...

Related

Tags: Africa Bureau chiefAIDS Healthcare FoundationFeaturedHow big pharmaceuticals’ greed for profit harms lives

Related Posts

The write, Hellen Masika is a Community Mobilizer at Centre for Citizens Conserving Environment & Management (CECIC)
OpED

 HELLEM MASIKA: The Impact of Climate Change on Healthcare in Uganda, Challenges and Pathways to Resilience

by UG STANDARD EDITOR | UG STANDARD EDITORIAL
10/10/2024
0
274

The write, Hellen Masika is a Community Mobilizer at Centre for Citizens Conserving Environment & Management (CECIC) Climate change is...

Read moreDetails
The writer, Emma Bwayo is Young Politician, Journalist, and Law Student (PHOTO/Courtesy)

#UGAT62: The Youth Perspective and President Museveni’s Role in Shaping the Future

08/10/2024
340
President Museveni and his son, Muhoozi Kainerugaba (PHOTO/Courtesy)

2026 CRISIS: Is it Gen Museveni or his son Gen Muhoozi

11/03/2023
250
Hellen Masika, Community Mobilizer at CECIC, empowering communities for environmental conservation.

A Brewing Crisis: Climate Change and Uganda’s Coffee Industry 

18/09/2024
195
Load More

Popular Articles

  • Check out the top schools with pupils who scored 6 in 4 aggregates in the 2024 PLE results, as released by UNEB

    PLE 2024 Results: Top Schools with 6 in 4 Aggregates

    4370 shares
    Share 1748 Tweet 1093
  • How to Renew Your National ID Online: NIRA Pre-Registration Portal 2025 Guide

    3996 shares
    Share 1598 Tweet 999
  • NIRA unveils high-tech National ID, mass enrollment set to begin

    2665 shares
    Share 1066 Tweet 666
  • FULL LIST: Ministry of Education, NCDC publish self-study workbooks amid COVID-19 lockdown

    3323 shares
    Share 1348 Tweet 823
  • How to Check PLE Results 2024 on Phone, Online

    1784 shares
    Share 714 Tweet 446
  • PLE 2024 Results: UNEB Clarifies on Release Date

    1650 shares
    Share 660 Tweet 413
  • MPs clear govt to cancel 2020 academic year

    2796 shares
    Share 1150 Tweet 686

Recent Articles

Outrage in Rushenyi: Health Centres Caught in Storm Over Allegedly Stolen Campaign Donations

08/07/2025

Court convicts four Lira District officials for fraudulently procuring a land title on a Forest Reserve

08/07/2025
UHRC Chairperson, Lady Justice Mariam Wangadya, Commissioners of UHRC and other stakeholders who participated in the workshop.

Human Rights Record: UHRC Prepares government agencies for UN periodic review

08/07/2025
David and Deborah Mutaaga, aged 69 and 62, were stabbed to death in their Entebbe home. Police are investigating the crime, which showed no signs of forced entry.

Police Investigate Grisly Double Murder in Entebbe

08/07/2025
trade: Uganda and Kenya's joint mission in Kampala seeks to remove barriers, promote investment, and build stronger economic ties in East Africa.

Uganda, Kenya Forge Deeper Trade Ties at Kampala Mission

08/07/2025

Study: Men Link Love, Self-Worth to Providing Role

08/07/2025
Christopher Legilisho, an economist at Stanbic Bank,

Businesses Optimistic About Uganda’s Future

07/07/2025

Recent CommentsRecent Comments

  • The Journey of Ibrahim Traoré on How President Ibrahim Traoré’s ambitious vision is driving Burkina Faso’s economic growth push
  • Ugandan Scientists Finalists For European Inventors Prize — Press Uganda on Ugandan scientists finalists for European inventors prize
  • Government Pumps UGX1 Trillion Into UDB To Drive Industrialization, SME Growth — Press Uganda on Government pumps UGX1 Trillion into UDB to drive Industrialization, SME growth
  • PS Ggoobi Tips On Building USD 500b Economy — Press Uganda on PS Ggoobi tips on building USD 500b economy
  • Museveni Meets German Envoy Matthias Schauer After Subversion Claims — Press Uganda on Museveni meets German envoy Matthias Schauer after subversion claims

UG Standard - Latest News

UG Standard, published via www.ugstandard.com isa publication of Sahel Media Solutions Ltd, a professional Digital/New Media company in Uganda info@ugstandard.com

Follow us on social media:

Latest News

  • Outrage in Rushenyi: Health Centres Caught in Storm Over Allegedly Stolen Campaign Donations
  • Court convicts four Lira District officials for fraudulently procuring a land title on a Forest Reserve
  • Human Rights Record: UHRC Prepares government agencies for UN periodic review
  • Police Investigate Grisly Double Murder in Entebbe
  • Uganda, Kenya Forge Deeper Trade Ties at Kampala Mission
  • Study: Men Link Love, Self-Worth to Providing Role

OpED

HELLEN MASIKA: From Darkness to Solar Light in Kijumba 

Why de-register a Motor Vehicle in Uganda: and Consequences of Non-Compliance

Challenges of taxing law firms in Uganda

SHEILA ABOTH: Maternal healthcare must be everyone’s business because it takes a village

DARIUS NIWAHA KISHAHO: Securing Health After Retirement: Why a Post-Retirement Medical Cover is a Necessity, Not a Luxury

© 2024 Ugstandard - Latest News by Digital/New Media company.

Welcome Back!

Sign In with Facebook
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • DIPLOMACY
    • COURT
    • AFRICA
    • BOOK REVIEW
    • INTERVIEW:
    • National
    • Parliament
    • World
    • Regional
  • Business
    • AGRIBUSINESS
    • OIL & GAS
    • REAL ESTATE
    • TECH
    • INNOVATIONS
    • TELCOM
  • OpED
  • EDUCATION
  • INVESTIGATION
    • NATIONAL ARCHIVE
    • SPECIAL REPORT
    • ANALYSIS
  • FEATURES
    • SOCIETY
    • Community
    • Pictorial
    • PROFILES
    • Lifestyle
    • Health
    • ENVIRONMENT
  • Tours & Travel
    • Hotel & Hospitality
  • Sports
  • About Us

© 2024 Ugstandard - Latest News by Digital/New Media company.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
%d